Itonis, Inc. narrows its selection for its anti-nausea
product Emesyl to two manufacturers
LAGUNA HILLS, CA -- December 30, 2015 -- InvestorsHub
NewsWire -- Itonis, Inc. (OTC PINKSHEETS: ITNS) Itonis,
Inc. is pleased to announce that it has narrowed its selection to
two homeopathic manufacturers for the production of its anti-nausea
product Emesyl.
The company has been searching for a new homeopathic
manufacturer for Emesyl since Oasis Health Products went out of
business and failed to deliver 15,000 units from its initial fully
paid product order. Selection of the new manufacturer will be
announced early 2016 and newly manufactured Emesyl product is
expected to be back in the pipeline for sale immediately after
completion of stability testing on the first new lot.
The company will also move forward with the release of the
10,000 commercial spots it previously announced to be aired on
cable TV, once new product is manufactured and back in the
pipeline. The company was forced to put this project on hold when
product availability came to a halt as the result of Oasis Health
Products going out of business.
Additionally, the company has been working with its software
developer to upgrade the Emesyl.com website to a new platform,
which will include an online shopping cart. This will allow for
direct consumer purchase of Emesyl from the website.
The Oasis issue was a huge setback for us said Steve Pidliskey,
Itonis Vice President. We knew up front that the selection of a new
homeopathic manufacturer with proper FDA registered facilities
would be a time consuming process. Fortunately, were back on our
feet now, and were confident that our goal of making Emesyl a
household name will be achieved.
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis
Inc. has focused on the distribution of innovative products to the
medical and pharmaceutical industries. The company also holds a
licensing agreement with MyECheck Inc, which allows the company to
use MyEChecks patented mobile payment application and share
transaction revenue fees for point of purchase payments across
various industries. Please visit www.itonisholdings.com for additional information.
Safe Harbor:
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's affiliates that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, seasonal
changes, and other risks detailed from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The actual results may differ materially from those contained in
this press release. The Company disclaims any obligation to update
any statements in this press release.
Contact:
Itonis, Inc.
Office@itonisholdings.com
